NCT06721247 (Mg in asthma) is a Phase 2, PHASE3 clinical trial of Magnesium in Bronchial Asthma, sponsored by Zagazig University.

Who is sponsoring NCT06721247?

NCT06721247 is sponsored by Zagazig University.

What drugs are being tested in NCT06721247?

Interventions in NCT06721247: Magnesium, ICS+LABA.

What condition does NCT06721247 study?

NCT06721247 studies Bronchial Asthma.

Is NCT06721247 still recruiting?

NCT06721247 is currently active, enrolled. Last updated 14 August 2025.

Last reviewed 2025-08-14 · How we verify

NCT06721247: Mg in asthma

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Intake of Mg in Controlled Asthmatic Patients

Active, enrolled Phase 2, PHASE3 Last updated 14 August 2025

What this trial tests

Phase 2, PHASE3 trial testing Magnesium in Bronchial Asthma in 166 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 November 2024

Primary endpoint
2 November 2025

2 November 2025

Quick facts

Lead sponsor	Zagazig University
Phase	Phase 2, PHASE3
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	166
Start date	2 November 2024
Primary completion	2 November 2025
Estimated completion	2 November 2025
Sites	1 location across Egypt

Drugs / interventions tested

Magnesium — full drug profile →
ICS+LABA — full drug profile →

Conditions studied

Bronchial Asthma — all drugs for Bronchial Asthma →

Sponsor

Zagazig University

Who can join

18 and older, any sex, with Bronchial Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to assess the efficacy of oral magnesium supplements in controlled asthmatic patients for proper effective asthma management to reduce frequency of asthma exacerbation \& to test the effect of oral magnesium supplementation on improvement of both clinical symptoms and lung functions in patients with bronchial asthma.. The main questions it aims to answer are: • Can oral supplementation of magnesium play a role in decrease the number of bronchial asthma exacerbations , number of ER visits , number of doctor visits and improve lung function ? Researchers will compare patients on usual treatment according to GINA guidelines 2024 group B and those taking oral magnesium together with the usual group A . Participants will: * Take oral magnesium treatment with usual asthma medications according to GINA guidelines (2024) every day for 1year * Visit the clinic once every 2 weeks for checkups and tests * Keep a diary of their day and night symptoms and the number of times they had activity limitation due to asthma and the number of use reliever.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Magnesium

Trials testing the same drug.

NCT07502482 — The Effect of Magnesium on Post-spinal Headaches · not yet recruiting
NCT07309640 — The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With · NA · not yet recruiting
NCT07082894 — Effect of Preoperative Oral Magnesium on Emergence Agitation · NA · completed
NCT07521358 — Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression · NA · completed
NCT07079514 — Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients · Phase 1, PHASE2 · completed

Other recruiting trials for Bronchial Asthma

Currently open trials in the same condition.

NCT07183657 — Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and · NA · recruiting
NCT07054034 — Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects · Phase 2 · active not recruiting
NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
NCT06852911 — FeNO Detection in Asthma Diagnosis: A New Technology Approach · NA · recruiting
NCT05632081 — A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE) · recruiting

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06721247 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 14 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06721247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing